JP2006503017A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503017A5 JP2006503017A5 JP2004532284A JP2004532284A JP2006503017A5 JP 2006503017 A5 JP2006503017 A5 JP 2006503017A5 JP 2004532284 A JP2004532284 A JP 2004532284A JP 2004532284 A JP2004532284 A JP 2004532284A JP 2006503017 A5 JP2006503017 A5 JP 2006503017A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- sequence
- immunogen
- immunogenic composition
- substitutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0220212A GB0220212D0 (en) | 2002-08-30 | 2002-08-30 | Vaccine |
| GB0304672A GB0304672D0 (en) | 2003-02-28 | 2003-02-28 | Vaccines |
| PCT/GB2003/003703 WO2004019974A2 (en) | 2002-08-30 | 2003-08-28 | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006503017A JP2006503017A (ja) | 2006-01-26 |
| JP2006503017A5 true JP2006503017A5 (https=) | 2006-06-15 |
Family
ID=31980003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004532284A Pending JP2006503017A (ja) | 2002-08-30 | 2003-08-28 | Ｉｌ−１３要素及びｔ細胞エピトープを含む免疫原組成物並びにその治療上の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060147417A1 (https=) |
| EP (1) | EP1532172A2 (https=) |
| JP (1) | JP2006503017A (https=) |
| AR (1) | AR041086A1 (https=) |
| AU (1) | AU2003259358A1 (https=) |
| CA (1) | CA2496409A1 (https=) |
| TW (1) | TW200407162A (https=) |
| WO (1) | WO2004019974A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004019975A2 (en) * | 2002-08-30 | 2004-03-11 | Glaxo Group Limited | Il-14 vaccine for the treatment of asthma and atopic disorders |
| PL3718564T3 (pl) | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| DE102004003572A1 (de) * | 2004-01-23 | 2005-08-18 | Bavarian Nordic A/S | Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens |
| KR100639397B1 (ko) * | 2004-03-18 | 2006-10-26 | (주)에스제이바이오메드 | 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물 |
| EP1824886B1 (en) | 2004-11-17 | 2010-12-22 | Amgen Inc. | Fully human monoclonal antibodies to il-13 |
| GB0615881D0 (en) * | 2006-08-10 | 2006-09-20 | Univ Southampton | Novel peptide for treatment of asthma |
| MX2009003188A (es) * | 2006-09-25 | 2009-05-22 | Sj Biomedic Inc | Polipeptidos hibridos inmunogenicos antiobesidad y composicion de vacuna antiobesidad que comprende los mismos. |
| WO2011003138A1 (en) * | 2009-07-06 | 2011-01-13 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| WO2015017034A1 (en) * | 2013-08-02 | 2015-02-05 | Gourdie Robert G | Methods of treating a cancer through targeted disruption of alpha connexin 43-zonula occludens-1 (zo-1) interaction |
| CN120904322A (zh) | 2013-09-13 | 2025-11-07 | 豪夫迈·罗氏有限公司 | 包含纯化的重组多肽的方法和组合物 |
| RU2016107435A (ru) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты |
| WO2019061297A1 (zh) * | 2017-09-29 | 2019-04-04 | 苏州工业园区唯可达生物科技有限公司 | 一种cd4辅助性t细胞表位融合肽及其疫苗 |
| EP3574915A1 (en) | 2018-05-29 | 2019-12-04 | Neovacs | Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity |
| JP7569091B2 (ja) | 2018-12-28 | 2024-10-17 | ユナイテッド・バイオメディカル・インコーポレーテッド | インターロイキン６（ｉｌ－６）調節異常による影響を受ける疾患の免疫療法のための、ｉｌ－６を標的とするペプチド免疫原及びその製剤 |
| JP2024504194A (ja) * | 2021-01-29 | 2024-01-30 | エランコ アニマル ヘルス ゲー・エム・ベー・ハー | 自己寛容を破壊するためのワクチン組成物 |
| CA3229324A1 (en) * | 2021-08-20 | 2023-02-23 | Beatrice DROUET | Mrna vaccines comprising il-4 and/or il-13 rna and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| US6296843B1 (en) * | 1998-04-03 | 2001-10-02 | The Penn State Research Foundation | Mutagenized IL 13-based chimeric molecules |
| HUP0200958A3 (en) * | 1999-04-23 | 2004-11-29 | Pharmexa As | Method for down-regulating il5 activity |
| EP1263785A2 (en) * | 1999-11-11 | 2002-12-11 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Mutated il-13 molecules and their uses |
| US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
| GB0105360D0 (en) * | 2001-03-03 | 2001-04-18 | Glaxo Group Ltd | Chimaeric immunogens |
-
2003
- 2003-08-28 JP JP2004532284A patent/JP2006503017A/ja active Pending
- 2003-08-28 AU AU2003259358A patent/AU2003259358A1/en not_active Abandoned
- 2003-08-28 EP EP03791019A patent/EP1532172A2/en not_active Withdrawn
- 2003-08-28 TW TW092123745A patent/TW200407162A/zh unknown
- 2003-08-28 US US10/526,060 patent/US20060147417A1/en not_active Abandoned
- 2003-08-28 WO PCT/GB2003/003703 patent/WO2004019974A2/en not_active Ceased
- 2003-08-28 AR ARP030103127A patent/AR041086A1/es not_active Application Discontinuation
- 2003-08-28 CA CA002496409A patent/CA2496409A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503017A5 (https=) | ||
| Theisen et al. | Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | |
| CA1340472C (en) | Universal t-cell epitope derived from p. faciparum circumsporosoite protein | |
| EP1092774B1 (en) | Borrelia burgdorferi OspA polypeptide for immunization against Lyme disease | |
| AU637049B2 (en) | Recombinant flagellin vaccines | |
| WO1992000055A1 (en) | Compositions and methods for the prevention and diagnosis of lyme disease | |
| RU2007146137A (ru) | Иммуногенные композиции на основе chlamydia trachomatis | |
| CA2565925C (en) | Vaccine for periodontal disease | |
| JP2005502314A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| JPS6251994A (ja) | クロ−ン化抗原 | |
| JPH08509371A (ja) | ライム病の予防及び治療のためのＯｓｐＣ抗原ワクチンの免疫原性製剤及びかかる抗原の調製のための組換え方法 | |
| EP3029073B1 (en) | Polyvalent chimeric ospc vaccinogen and diagnostic antigen | |
| JP2006501249A5 (https=) | ||
| EP0638092A1 (en) | Synthetic peptide vaccines for dental caries | |
| KR102507993B1 (ko) | 박테리아 표면 수용체 단백질로부터 유래된 면역원성 조성물 및 백신 | |
| JP3135060B2 (ja) | ヘモフィルスインフルエンザｂ型菌の外皮膜タンパク質Ｐ２の部分断片を用いた接合体 | |
| US12220453B2 (en) | Compositions and treatments for Haemophilus influenzae | |
| CN101880328A (zh) | 微小隐孢子虫Th多表位基因和融合蛋白及其应用 | |
| AU2001271124B2 (en) | Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis | |
| CN1187372C (zh) | 人绒毛膜促性腺激素基因工程合成嵌合肽及其制备方法 | |
| AU2001271124A1 (en) | Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis | |
| JPS63503197A (ja) | マラリアに対する保護免疫を与えるポリペプチド類 | |
| WO2002017960A1 (fr) | Vaccins contre $m(f)i$m(g)toxoplasma gondii$m(f)/i$m(g) | |
| Lindberg et al. | Nobel Symposium 69. The Vaccines of the Future |